December 15, 2025

Doctors Push Back on FDA Antidepressant Fears

After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.

KFF Health News

December 05, 2025

On the Edge of a Measles Comeback?

New analysis examines rising U.S. measles outbreaks, associated clinical risks, and the potential loss of measles-elimination status.

KFF Health News

December 05, 2025

Fancy Gadgets, Higher Bills: HSA Era

Republican proposals to expand health savings accounts amid expiring ACA subsidies outline potential shifts in coverage costs and limitations in how patients may use HSA funds.

KFF Health News

December 04, 2025

FDA Approves Biologic for Nerve Repair

A newly licensed biologic offers a novel approach to repairing complex peripheral nerve injuries across pediatric and adult populations.

Conexiant

December 04, 2025

HHS Communications in Transition

Why HHS messaging is shifting, and what it means for patient trust.

KFF Health News

November 25, 2025

FDA OKs First SMA Gene Replacement Therapy

The FDA approved Itvisma, the first gene replacement therapy for children 2 years and older, teens, and adults with spinal muscular atrophy, a one-time treatment that replaces the SMN1 gene and demonstrated improved motor function in Phase 3 studies.

Conexiant

November 24, 2025

‘It Should Have Never Been Published’ Debate Continues

Experts counter Robert F. Kennedy Jr.’s claims about aluminum adjuvant safety, noting extensive evidence that aluminum-containing vaccines remain effective and well-validated.

KFF Health News

November 24, 2025

Why Youth E-Bike Injuries Are Increasing

Rising youth e-bike use and injuries amid limited federal oversight and evolving state safety rules.

KFF Health News

November 21, 2025

‘Gold-Standard Science’ Meets a Rewrite

Revisions to a key CDC webpage have unsettled clinicians, who worry the changes could erode confidence in established vaccine science.

KFF Health News